Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Dec;50(12):1027–1028. doi: 10.1136/jcp.50.12.1027

Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.

E J Threlfall 1, A Graham 1, T Cheasty 1, L R Ward 1, B Rowe 1
PMCID: PMC500386  PMID: 9516887

Abstract

In 1996, 6% of Escherichia coli from extraintestinal infections were resistant to ciprofloxacin with minimum inhibitory concentrations (MICs) > or = 2 mg/l (high level resistance). Low level resistance (MIC 0.125-1 mg/l) was also identified in 7% of Salmonella typhi, 4% of S paratyphi A, and 4% of non-typhoidal salmonellas. However, resistance to ciprofloxacin was rarely identified in shigellas. For E coli, physicians should be aware that treatment failures may occur when patients with invasive illness are treated with ciprofloxacin before the results of laboratory sensitivity tests are available. For salmonellas an increasing number of treatment failures have been recorded for patients infected with strains with low level resistance. Because of the increasing incidence of Enterobacteriaceae with low level resistance to ciprofloxacin, it is recommended that for this group of organisms a breakpoint of 0.125 mg/l should be included in laboratory sensitivity tests.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Everett M. J., Jin Y. F., Ricci V., Piddock L. J. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother. 1996 Oct;40(10):2380–2386. doi: 10.1128/aac.40.10.2380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Frost J. A., Kelleher A., Rowe B. Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994. J Antimicrob Chemother. 1996 Jan;37(1):85–91. doi: 10.1093/jac/37.1.85. [DOI] [PubMed] [Google Scholar]
  3. Murphy O. M., Marshall C., Stewart D., Freeman R. Ciprofloxacin-resistant Enterobacteriaceae. Lancet. 1997 Apr 5;349(9057):1028–1029. doi: 10.1016/s0140-6736(05)62932-7. [DOI] [PubMed] [Google Scholar]
  4. Piddock L. J., Whale K., Wise R. Quinolone resistance in salmonella: clinical experience. Lancet. 1990 Jun 16;335(8703):1459–1459. doi: 10.1016/0140-6736(90)91484-r. [DOI] [PubMed] [Google Scholar]
  5. Threlfall E. J., Cheasty T., Graham A., Rowe B. High-level resistance to ciprofloxacin in Escherichia coli. Lancet. 1997 Feb 8;349(9049):403–403. doi: 10.1016/s0140-6736(97)80024-4. [DOI] [PubMed] [Google Scholar]
  6. Threlfall E. J., Ward L. R., Skinner J. A., Rowe B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist. 1997 Fall;3(3):263–266. doi: 10.1089/mdr.1997.3.263. [DOI] [PubMed] [Google Scholar]
  7. Umasankar S., Wall R. A., Berger J. A case of ciprofloxacin-resistant typhoid fever. Commun Dis Rep CDR Rev. 1992 Nov 6;2(12):R139–R140. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES